SCHEMBL327129

SCHEMBL327129

CC12C[C]3CC(C1)CC(C)(C3)C2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 6/20 0.41
GRIN2A Q12879 6/20 0.41
GRIN2D O15399 5/20 0.41
GRIN3B O60391 5/20 0.41
GRIN2B Q13224 5/20 0.41
GRIN2C Q14957 5/20 0.41
GRIN3A Q8TCU5 5/20 0.41
LMNA P02545 2/20 0.39
SLC22A1 O15245 1/20 0.39
ESR1 P03372 1/20 0.39
ADRB3 P13945 1/20 0.39
ACHE P22303 1/20 0.39
OPRK1 P41145 1/20 0.39
MTOR P42345 1/20 0.39
HTT P42858 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
NFKB1 P19838 1/20 0.39
CYP2C19 P33261 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6003126 0.83 GRIN1 (0.50) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL987369 0.83 GRIN2D (0.31) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL4034994 0.79 MEN1 (0.37) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL20660558 0.76 GRIN2D (0.41) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL3293369 0.75 GRIN2D (0.33) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL5708781 0.75
SCHEMBL10433767 0.70 GRIN2D (0.31) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL812216 0.68 GRIN1 (0.68) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
SCHEMBL1064437 0.68 GRIN2D (0.31) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B
Ammonia Solution, Strong SCHEMBL14695768 0.66 GRIN1 (0.65) GRIN1GRIN2AGRIN2DGRIN3BGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 520 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118019736-A Molecular gel compound designed based on cereblon protein and application thereof 标新生物医药科技(上海)有限公司 2024-05-10 CN claimed
EP-4222180-B1 BIS(HETEROCYCLIC-OLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF EXXONMOBIL CHEMICAL PATENTS INC (US) 2024-04-10 EP claimed
WO-2024051766-A1 MOLECULAR GLUE COMPOUND BASED ON CEREBLON PROTEIN DESIGN AND USE THEREOF 标新生物医药科技(上海)有限公司 2024-03-14 WO claimed
WO-2024000342-A1 HYDROPHILICALLY MODIFIED POLYISOCYANATE, AND PREPARATION METHOD THEREFOR AND USE THEREOF 万华化学集团股份有限公司 2024-01-04 WO claimed
CN-115010902-B Hydrophilic modified polyisocyanate and preparation method and application thereof 万华化学集团股份有限公司 2023-08-11 CN claimed
EP-4222180-A1 BIS(HETEROCYCLIC-OLATE) LEWIS BASE CATALYSTS AND METHODS THEREOF ExxonMobil Chemical Patents Inc. (US) 2023-08-09 EP claimed
CN-116323694-A Bis (heterocyclic-alkoxide) lewis base catalysts and methods thereof 埃克森美孚化学专利公司 2023-06-23 CN claimed
CN-111606883-B Sulfur-containing compound based on glutarimide skeleton and application thereof 上海科技大学 2023-05-09 CN claimed
CN-115819720-A Composite sulfonic acid modified polyisocyanate, preparation method and application thereof 万华化学集团股份有限公司 2023-03-21 CN claimed
CN-115010902-A Hydrophilic modified polyisocyanate and preparation method and application thereof 万华化学集团股份有限公司 2022-09-06 CN claimed
EP-1037878-A2 METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES NPS PHARMACEUTICALS, INC. (US) 2000-09-27 EP claimed
CN-1056615-C difluoro pentapeptide derivative anti-inflammatory agents PROCTER & GAMBLE (US) 2000-09-20 CN claimed
EP-1025079-A1 $g(a)-ARYL-$i(N)-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME CENTAUR PHARMACEUTICALS, INC. (US) 2000-08-09 EP claimed
US-6046232-A THERAPEUTICS FOR TREATING AND/OR PREVENTING NEUROLOGICAL, AUTOIMMUNE AND INFLAMMATORY CONDITIONS IN MAMMALS AND AS ANALYTICAL REAGENTS FOR DETECTING FREE RADICALS CENTAUR PHARMACEUTICALS, INC. (US) 2000-04-04 US claimed
EP-0904043-B1 HIGH LATHER STYLING SHAMPOOS PROCTER & GAMBLE (US) 2000-02-02 EP claimed
EP-0859819-B1 HEAT-ACTIVATABLE ADHESIVE COMPOSITION MINNESOTA MINING & MFG (US) 1999-12-29 EP claimed
WO-1999026927-A2 METABOTROPIC GLUTAMATE RECEPTOR ANTAGONISTS FOR TREATING CENTRAL NERVOUS SYSTEM DISEASES NPS PHARMACEUTICALS, INC. (US) 1999-06-03 WO claimed
WO-1999020601-A1 α-ARYL-N-ALKYLNITRONES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME CENTAUR PHARMACEUTICALS, INC. (US) 1999-04-29 WO claimed
CN-1095072-A Difluoro pentapeptide derivative anti-inflammatory agents PROCTER & GAMBLE (US) 1994-11-16 CN claimed
EP-0154339-B1 OPTICAL FIBER SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1989-06-07 EP claimed